Objective. To our knowledge, this is the first study assessing brain activation in response to painful stimulation over disease-relevant (finger joint) vs. neutral area (thumb nail) in patients suffering from rheumatoid arthritis (RA) compared to healthy controls (HC).
Introduction
Pain is one of the utmost challenging symptoms in Rheumatoid Arthritis (RA) and the primary reason for patients to seek medical care (Klooster et al., 2007) . Cross-sectional (Lee et al., 2018a) and longitudinal studies (>1 year, Baker et al., 2017; >5 year, Glinatsi et al., 2018) of RA suggest that pain sensitization is associated with objective markers of inflammation (but not destruction) of the affected person's joints. Although inflammation is a rich contributor to pain in RA, it may not be the only factor, as pain can persist despite therapeutic improvements in peripheral joint inflammation (Rupp et al., 2006; Wolfe et al., 2007; Altawil et al., 2016; Lee et al., 2011) , and increased pain sensitivity in non-inflamed tissue may particularly be found in patients with longstanding RA disease (Leffler et al., 2002) . In an 8-year longitudinal follow-up study, pain and disability measures were compared in an early RA patient cohort enrolled in the 1990s (n = 928) with an early RA cohort enrolled in the 2000s (n = 1010). Despite more active treatment in the 2000s, the early RA patients enrolled in the 2000s did not experience less pain and disability compared to the early RA patients enrolled in the 1990s over the course of 8 years follow up (Andersson et al., 2017) .
This suggests that more active dampening of peripheral inflammation is not directly related to a reduction in RA symptomatology.
Accumulating research suggest that RA is accompanied with changes in structural brain organization (Wartolowska et al., 2012; Schrepf et al., 2018) , and functional connectivity (Flodin et al., 2016; Schrepf et al., 2018) , as well as altered central pain processing (Jones & Derbyshire, 1997) . It has also been shown that psychological comorbidities like depression influence cerebral pain processing in RA (Schweinhardt et al., 2008) . However, few neuroimaging studies of RA to date, have included a healthy pain-free control group (HC), hampering identification of disease-specific mechanisms underlying central pain processing in RA.
To our knowledge, only two studies have investigated both the neural mechanisms of pain processing in RA patients and compared them with HC. Using different methodologies, results remain dispersed. The first study was conducted by Jones & Derbyshire in 1997, who used positron-emission tomography (PET) to compare the neural mechanisms of pain processing in response to thermal heat pain delivered to the back of the hand in RA patients (n = 6) and HC (n = 6). The results showed that RA patients had significantly reduced activity to induced thermal heat pain in prefrontal cortex (PFC, BA10), anterior cingulate cortex/midcingulate cortex (ACC/MCC, BA32 and BA24) compared to HC (Jones and Derbyshire, 1997) . The second study was conducted by Lee et al (2018b) , who used block-design pulsed arterial spin labelling (pASL) to compare cerebral processing of pressure stimuli applied to metacarpophalangeal joints between RA patients (n = 16) and HC (n = 16). High painful pressure was subjectively calibrated to correspond to a VAS rating of 40/100mm in RA, but reported as mildly or non-painful in HC. No significant group differences were found. However, within RA patients only, joint pressure stimulus yielded increased activation in medial frontal cortex (MFC) extending to dorsolateral prefrontal cortex (dlPFC).
Finally, two studies have used functional magnetic resonance imaging (fMRI) to investigate sensitivity to applied experimental pressure pain to the joints of RA patients, but none of them included a control group, since their primary aims were to investigate neurophysiological interactions between central pain processing and depression (Schweinhardt et al., 2008) , and exploring whether brain activity in RA patients can predict their treatment-response to tumour necrosis factor inhibitors (Rech et al., 2013) .
The present study is, to our knowledge, first to use the temporal advantages of event-related fMRI to investigate central pain processing in RA patients compared to HC. In order to compensate for peripheral/spinal sensitization in the RA group (Meeus et al., 2012) , the pressure pain stimuli were calibrated to the same subjective pain intensity across groups and sites. Our aim was to assess if RA patients had abnormalities in cerebral pain processing, and if so, whether the abnormalities were restricted to pain in disease-relevant parts of the body (i.e., inflamed joints), or more generalized (i.e., also including non-affected body parts such as the thumbnail).
Patients and Method

Patients Inclusion/Exclusion Criteria and Overall Procedure
RA patients were recruited to a randomized, placebo-controlled trial investigating the effects of a tumour necrosis factor (TNF-alpha) inhibitor on inflammation and pain in RA with baseline comparison with healthy subjects (the PARADE study; www.clinicaltrials.gov; [identifier NCT01197144, EudraCT 2009-017163-42] ) through the rheumatology clinic at the Karolinska Hospital in Stockholm, Sweden. Eligible patients (n = 40) were recruited in consecutive order, see flowchart (Figure 1) . In this paper, only the results from baseline data before initiation of drug or placebo are reported. In total, fMRI scans of 31 RA patients and 23 HC were analyzed, see Table 1 for patient and healthy control characteristics. All patients were screened by a MD. Eligible patients were fulfilling the ACR 1987 classification criteria for RA (Arnett et al., 1988) , working age (≥ 18 years), clinical indication for use of TNFblockers, and approved for MR examination. Exclusion criteria were left handedness, fibromyalgia comorbidity, neurological disease, comorbid depression, ongoing treatment with antidepressants, severe cardiovascular disease, latent tuberculosis, claustrophobia, pregnancy, previous treatment with biologics or other motives based on the judgment of the responsible physician. A specialist in rheumatology identified the most inflamed finger joint to be assessed in RA patients. HC were recruited in parallel to the RA patients, with the attempt to balance sex and age between the groups. Exclusion criteria for the HC were identical to the RA patients, with the additional exclusion criteria of recurrent pain problems, including RA and fibromyalgia. HC were also excluded if they reported regular use of over-the-counter pain medication or use of prescribed analgesics. The controls were recruited through noticeboards advertisements primarily at the hospital campus. Study personnel, behavioural testing, scan protocol, and facilities used to examine HC were the same as used for RA patients. Following inclusion, all subjects visited the pain laboratory on two consecutive days. During the first visit, subjects underwent thermal testing (heat/cold), temporal summation with heat, pressure pain algometry and pressure pain calibrations. During the second visit, subjects underwent brain scanning. The scanner protocol started with applying a localizer, followed by the pressure pain paradigm, resting state, T1 anatomical scan, and T2 flair.
The study conformed with Swedish legislation regarding clinical pharmacological trials and necessary permit from the Swedish medical products agency was obtained. The regional ethics committee in Stockholm approved the study and verbal as well as written informed consent was obtained from all participants.
Clinical Symptom Measurement
Disease activity was assessed through the disease-activity score based on 28 joint count (DAS28; Prevoo et al., 1995) . Functional status in RA patients was measured using the modified 20-item Health Assessment Questionnaire (HAQ; Fries et al., 1980) . Anxiety and depression were assessed with 14-item Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) . Current health state was assessed with Euro Quality of Life 5-dimension scale (EQ-5D; EuroQol group, 1990). Current pain was assessed using the visual analogue scale (VAS; Scott & Huskisson, 1976) prior to entering the scanner.
Procedure Day 1: Subjective Calibration of Pressure Pain Stimuli
During the first day, pressure pain sensitivity was determined using an automated, pneumatic, computer-controlled stimulator that applies pressure via a plastic piston with a 1 cm 2 hard rubber probe (Jensen et al., 2009 ) placed on the clinically most affected proximal interphalangeal (PIP) joint of the patient's left hand (PIP2 n = 25; PIP3 n = 6) and nonaffected left thumbnail. Each subject was calibrated for subjective pain ratings by receiving one ascending series, followed by one randomized series, of pressure stimuli. In both series, pressure pain was applied for 2.5 s with 30 s intervals and subjects were instructed to rate the pain intensity evoked by each stimulus on a visual analogue scale (VAS), ranging from 0 = no pain, to 100 = worst imaginable pain. In the ascending series, stimuli were applied with increasing steps of 50 kPa to determine the pressure pain threshold (PPT, first VAS > 0 mm) and stimulation maximum (SM, first VAS > 60 mm). Within the range of each subjects' subjectively calibrated PPT and SM pressures, five different pressure intensities were calculated and delivered three times each in a randomized series. A polynomial regressed function was used to determine each individual's representation of VAS 50 mm (designated as P50), constructed from the 15 ratings from the randomized series of pressure pain (see Jensen et al., 2009 for further information on the calibration procedure). The identical procedure was applied to the corresponding sites in HC.
Procedure Day 2: fMRI Acquisition
On the second day, all participants underwent stimulation in the MR scanner using their previously individually calibrated painful pressure (P50) and a non-painful pressure stimulus (50 kPa) during four runs (in pseudo-randomized order). In two runs stimuli were applied to the affected joint (or equivalent in HC) and in the other two runs stimuli were applied to the thumbnail. Each run consisted of 30 pressure stimuli, 15 painful and 15 non-painful stimuli, which were presented in a pseudo-randomized manner. All stimuli inside the MR scanner were delivered for 2.5s and jittered over time with a mean interval between onsets of stimuli of 15s (range 10-20s). Total duration of each run was 8.15 minutes. Prior to scanning, each subject was instructed to focus on the pressure delivered to the left thumbnail or joint and not to use any coping or distraction techniques. Pain ratings were not collected inside the scanner.
Resting state data (published elsewhere, see Flodin et al 2016) were collected at the end of the MR session. MR images were acquired with a 3T General Electric 750 MR scanner installed at the MR Research Center, Karolinska Institutet, Stockholm, using a 32-channel head coil. In each of the four sessions, 160 volumes covering the whole brain were acquired using a T2*-weighted single-shot gradient echo planar imaging sequence. The following parameters were used: TR/TE = 3000/30ms, flip angle = 90°, 96x96 matrix size, FOV = 288x288mm, 56
slices, slice thickness = 3 mm, acquired through an interleaved slice acquisition mode.
Anatomical MR scans were acquired with a high-resolution BRAVO 3D T1-weighted image sequence (1x1x1 mm voxel size, 176 slices). Anatomical (T2-weighted) scans were investigated by neuro-radiologist for clinical abnormalities.
Statistics
Behavioural data on pressure pain sensitivity was analysed in Rstudio (Version 1.1.456;
RStudio Team, 2015) , using the non-parametric Mann-Whitney U-test for calculating pressure pain sensitivity. Group differences in age were calculated by Students t-test. A threshold p <.05 was regarded as significant.
Functional Imaging Data Analysis
Imaging data analyses were performed using the Statistical Parametric Mapping 12 (SPM12) software (Friston et al., 1995;  http://www.fil.ion.ucl.ac.uk/spm/software/spm12/) running under Matlab2014 (MATLAB 2014, The MathWorks, Inc., Massachusetts, United States).
Prior to pre-processing, all scans were reoriented manually to the anterior/posterior commissure (AC/PC) line to improve the co-registration and normalization process. First, functional images were spatially realigned using a six-parameter affine transformation and registered to the mean. Then, individual structural images were co-registered with functional images. Finally, co-registered images were normalized to Montreal Neurological Institute (MNI) space and spatially smoothed using an 8mm Full-Width-Half-Maximum (FWHM)
Gaussian kernel. Data of all subjects were manually investigated for task-related head motion, none excluded. Frame-wise displacement (FD) was used to assess head motion from one volume to the next, converting rotational displacements (sum of the absolute values of the derivatives of the six realignment parameters) from degrees to millimetres by calculating displacement on a sphere with a 50mm radius. In total, 2 RA patients and 2 healthy subjects displayed excessive head motion (FD >0.5, in >15% of the images), and were thus excluded from further analyses. and [thumb(pain-sensory)]. Potential effects of age and sex on cerebral pain processing were investigated in RA and HC in order to decide whether to include these variables as covariates of no interest in our statistical model (i.e. in order to control for any age-or sex-related variance). Three correlational analyses were performed in order to investigate the relationship between cerebral pain processing in RA and disease-relevant parameters. Namely, DAS28
(including erythrocyte sedimentation rate, ESR; swollen joint count; tender joint count), disease duration (months), and VAS ratings prior to entering the scanner. In order to investigate potential effects of emotional distress or health state on cerebral joint and thumb pain processing in RA patients, secondary correlational analyses included HAD-Depression, HAD-Anxiety, and EQ-5D.
For all 2 nd level analyses, statistical significance was considered for cluster-level 
Psychophysiological Interaction Analysis
In order to further investigate disease-relevant differences in cerebral processing of painful stimuli, a Psychophysiological interaction (PPI) analysis (Friston et al., 1997) was performed based on the univariate fMRI results. This PPI analysis should be considered secondary, as it follows the results of the group contrast. A PPI analysis is can be considered as a simple connectivity model that falls in between effective-and functional connectivity. In brief, PPI
investigates the interaction between a source region based on a selected volume of interest (VOI) and an experimental condition (Friston et al., 1997) . As such, a PPI analysis can either be interpreted as demonstrating how the contribution of one region to another is altered by the experimental (psychological) context, or how one area's response to an experimental context is modulated by input from another region. Here, the physiological parameter was the selected VOI BOLD fMRI signal time-course from the right dlPFC and the psychological parameter was the experimental context of applied painful minus sensory stimulation. A 4mm radius spherical VOI was defined around the peak coordinate of significantly decreased activation from the within-group analysis of RA[joint(pain-sensory)] in the right dlPFC [MNI 24, 24, 50] . The purpose of the PPI seed placement was to further elucidate and aid the interpretation of the observed decreased fMRI BOLD signal in dlPFC in RA patients.
Results
Behavioral Results
The characteristics of RA patients and HC are presented in Table 1 , including symptom severity, pressure pain sensitivity and current treatments. There were no significant group differences in age. RA patients had increased pain sensitivity at the inflamed joints (median P50: RA=500kPa, HC=792kPa) (p < 0.005), but not at the thumbnail (median P50: RA= 507kPa, HC=501kPa) (NS), compared to HC (Table 1, Figure 2a ).
Neuroimaging Results
All participants revealed typical pain-related brain activation as a response to painful stimulation over joint as well as thumb in primary somatosensory cortex (S1), primary motor cortex (M1), secondary somatosensory cortex/rolandic operculum (S2); mid cingulate cortex (MCC), insula, thalamus, and cerebellum (for a detailed list of brain regions, see
Supplementary table 1).
Significant interaction was observed between [Group x Joint stimulation intensity]. When tested for directionality, the interaction was driven by HC>RA[Joint(painsensory)], in which RA patients exhibited significantly less brain activation in response to joint pain compared to HC in right supramarginal gyrus (SMG) extending to S1 and M1, right anterior insula (aIns) extending to S2, and right MCC (Table 2, Figure 2b ). There were no brain regions where RA patients exhibited greater activity compared to HC. No significant differences were found between HC and RA patients when painfully stimulated at the diseaseirrelevant control site, i.e. left thumbnail. No differences were found between the groups in cerebral response to sensory stimuli on either site. Healthy controls did not exhibit any difference in brain activity in response to painful stimulation at the two different sites of the body. However, within RA patients, we observed a significant interaction between [Site x
Stimulation intensity]. When tested for directionality, RA showed higher activation during stimulation on the thumb (pain-sensory) compared to the joint (pain-sensory) in bilateral S1, Depression, HAD-Anxiety, EQ-5D, nor VAS reports prior to entering the scanner. We found no significant effects of neither age nor sex on cerebral pain processing in our sample.
Psycho-physiological interaction (PPI) analysis, using a seed from the cluster in the right dlPFC [MNI 24, 24, 50] (Figure 3 ).
Discussion
The present study is, to our knowledge, the first to investigate disease-relevant mechanisms of cerebral pain processing in rheumatoid arthritis (RA, without fibromyalgia co-morbidity) compared to healthy controls (HC). Using an event-related fMRI paradigm that included evoked pressure pain, we observed altered cerebral pain processing in RA patients compared to HC. The alterations in RA patients were specific to painful stimulation at disease-affected, inflamed finger joints, and were not observed at the non-affected thumbnail. Compared to controls, RA patients had increased pressure pain sensitivity, exhibited significantly less activation in regions related to pain-and somatosensory processing (S1, S2, M1, aIns, SMG and MCC) and had decreased right dlPFC activation, psycho-physiologically interacting (PPI)
with the left dlPFC in response to painful stimulation at disease-affected joints. The current results show a local increase in pain sensitivity in combination with abnormal cerebral pain processing restricted to the disease-affected areas in RA, and are most likely explained by a combination of peripheral sensitization and aberrant processing of nociceptive input in cortico-cortical pathways.
Although both groups displayed typical whole-brain activation of pain-related brain regions (supplementary table) , RA patients exhibited significantly less pain related brain activation (S1, S2, M1, SMG, aINS and MCC) compared to HC when painfully stimulated at disease-affected joints (Figure 2b) . Further, RA patients also exhibited less pain related brain activation when painfully stimulated at disease-affected joints compared to the non-affected thumbnail (S1, S2, aINs and lingual gyrus) (Figure 2c ). In RA, movement of inflamed joints causes exacerbations of pain both during, and after activity. Since many activities of everyday life require multiple, repeated hand movements, altered somatosensory activity are likely to be found in RA patients. As the BOLD fMRI is a relative measure of a signal increase compared to a baseline (e.g. Ekström, 2010) , it may seem feasible to assume that the significantly lower task-based BOLD response in RA compared to HC reflects ongoing somatosensory activity in RA. That is, a higher activation in the pain-and somatosensory related areas in RA patients that is present before the evoked pressure pain could explain the smaller BOLD amplitude following painful stimulation of inflamed joints in the RA patients.
However, as we found no differences in brain activation during non-painful somatosensory stimuli to the joint between RA vs. HC, this effect may be specific for painful stimuli.
Another interpretation of the results is that RA patients exhibit less somatosensory nociceptive processing (S1, S2, aINS) compared to HC when painfully stimulated at a disease-affected site, as well as at a disease-affected vs. non-affected site within the RA group. This interpretation would be in line with findings that pain processing shifts from nociceptive somatosensory to emotional brain circuits during the chronification of pain (e.g., Apkarian et al., 2005; Baliki et al., 2013; Hashimi et al., 2013) . However, contrary to these studies, we did not see any pain related increases of activity in brain areas associated with "emotional" brain circuits (medial prefrontal cortex and amygdala) (Hashmi et al., 2013) . Therefore, we suggest that during increased joint pain, our RA patients exhibited reduced somatosensory nociceptive processing without increased activation of the emotional circuits.
Previous studies have indicated that activation of somatosensory cortex plays a role in pain intensity coding in humans (Lockwood et al., 2013) . In our previous resting-state study that was based on the current dataset, we observed increased functional connectivity in RA patients compared to HC between bilateral sensorimotor areas (S1, M1) and frontal midline (MCC, SMA) regions, which was interpreted as an adaptive mechanism serving to reduce the experience of pain (Flodin et al., 2016) . Notably, an opposing picture, suggesting sensory disintegration was seen in patients suffering from fibromyalgia, a condition characterized by pain facilitation (Flodin et al., 2014) . Taken together, a more comprehensive conclusion would be that RA patients adapt to the peripheral sensitization by an increased functional connectivity between pain regulatory frontal midline structures and sensorimotor areas allowing for a downregulation of sensory responses to noxious input from inflamed joints (Flodin et al., 2016) , thereby corresponding to the findings of the current study with reduced S1, S2, M1, aINS activation specifically during evoked pain from the most inflamed finger joints. However, other emotional and cognitive regulation mechanisms also need to be
considered. Yet, we found no effect of affective measures such as depression and anxiety on cerebral pain processing in our RA cohort, although it should be noted that comorbid depression and ongoing anti-depressant medication served as exclusion criteria in the current study, which may explain the very low, and clinically non-significant ratings of depression and anxiety in both groups.
During joint stimulation in the RA group, the contrast pain-sensory yielded significantly decreased BOLD activation in right dorsolateral prefrontal cortex (dlPFC), an area commonly associated with top-down regulation of pain and driving appropriate behavioural responses (Seminowicz & Moayedi, 2017) . No significant deactivations were seen in RA patients during evoked pain at the thumb, nor at any site in HC (Figure 3b ). The dlPFC has been suggested to be involved in the initiation of emotional and cognitive regulation in healthy (Kohn et al., 2014; Barbas et al., 2000; Gross 1998) , and various chronic pain cohorts (Seminowicz & Moayedi, 2017) . Particularly, while the posterior subregion of the dlPFC is related to action execution and working memory through functional coupling with bilateral intraparietal sulci, the anterior subregion of the dlPFC is associated with attention and action inhibitory processes through functional coupling with ACC (Cieslik et al., 2013) . In this way, the dlPFC is implicated in exerting top-down cognitive control to modulate flexible, adaptive behaviour in every-day life (Cieslik et al., 2013; Kohn et al., 2014) , including encoding and modulating pain (Seminowicz & Moayedi, 2017) . In particular, dlPFC exerts modulatory effects on pain processing through fronto-striatal-brain stem circuit (Wager & Atlas, 2015; Seminowicz & Moayedi, 2017) .
Executive attention is also important for placebo analgesia as appraisals of safety may lead to increased use of self-distraction strategies involving the dlPFC. In line with this way of thinking, are reports of dlPFC activation during opioid-dependent placebo analgesia (Wager & Atlas, 2015; Zubieta et al., 2005; Eippert et al., 2009 ). However, the right dlPFC is implicated in placebo, as well as the opposite effect, as it has been shown to be activated during expectations of analgesia but deactivated during expectations of pain (Lui et al., 2010) . The deactivation of the right dlPFC seen specifically during painful stimulation of the inflamed joint in our RA patients could therefore be interpreted as a nocebo response. If RA patients have learned to expect pain from their inflamed joints, the resulting nocebo response could hypothetically explain how the same subjective pain intensity could be reached, despite lower activation of pain-somatosensory brain regions. An alternative explanation would be that the input from inflamed joints is normally under a more pronounced ongoing dlPFC inhibition to minimize disturbance and enhance focus on valued activities. However, when a sufficient stimulus intensity is reached, the dlPFC is momentary deactivated to allow for processing of potentially important (protective) information from the joints.
Functional connectivity analysis in RA patients using the right dlPFC as a seed revealed significantly positive coupling between right dlPFC and left dlPFC during painful stimulation at the inflamed finger joints (Figure 3a) , as well as negative functional coupling between the right dlPFC and the right S2 at trend level (P(FWE) = 0.073). Positive functional coupling indicates that activity in both right and left dlPFC changes conjointly during the evoked pain (a decrease in our study). Negative functional coupling can be interpreted as opposite changes (i.e., decrease in right dlPFC and increase in S2). A high degree of connectivity between the right and left dlPFC has previously been associated with reduced pain sensitivity (Sevel et al., 2016) , and bilateral activations of dlPFC have been reported to inversely correlate with intensity and unpleasantness of evoked pain (Lorentz et al., 2003) .
Together with our behavioural findings of increased pain sensitivity at inflamed joints in RA patients, the observed decrease in right dlPFC interacting with the left dlPFC during joint pain stimulation, could speculatively reflect either a failed activation or a deactivation of top-down pain modulatory systems in RA patients. In alignment with this, the observed trend towards negative functional coupling between right dlPFC and S2 during joint pain, may reflect a failed dlPFC top-down inhibition of S2, eg. the opposite of what has previously been reported during placebo analgesia (Zeidan et al., 2015) . The latter would be in line with a nocebo response in our RA patients.
The dlPFC has been proposed a feasible therapeutic target in chronic pain, as non-invasive brain stimulation to the dlPFC has been shown to effectively manage both acute and chronic pain (for a review, see Seminowicz & Moayedi, 2017) . The dlPFC can activate rACC via opioid-dependent signaling and the rACC can in turn engage lower parts of the descending pain regulatory system (Eippert et al., 2009 ). The nociceptive signaling from inflamed RA joints could hypothetically be under tonic inhibition through opioid signaling from dlPFC, but this could be temporarily deactivated during phasic nociception to protect the inflamed joints from harm, thus maintaining the protective function of nociception. The latter would tally clinical observations that opioids, while reducing ongoing pain, do not affect movement-associated pain. This line of reasoning is also in accordance with the activation of dlPFC during tonic painful pressure stimulation (6 min) at the metacarpophalangeal joints in RA patients, which was not seen in controls (Lee et al., 2018b) , as well as with our present findings of deactivation of dlPFC during phasic joint, but not thumbnail, pain stimulation in RA patients, also not seen in controls. Similar to our results, Jones and Derbyshire (1997) found reduced regional cerebral blood flow in prefrontal cortex (BA10), on the anterior border to dlPFC, as a response to phasic thermal heat pain applied to the back of the hand in RA (n = 6) patients compared to HC. Notably, altered dlPFC structure and function has been widespread chronic pain syndrome characterized by a dysfunctional descending pain regulation, deficient dlPFC and rACC activation was seen during evoked pain stimulation (Jensen et al., 2009; Schrepf et al., 2016) and was related to reduced opioid signaling (Schrepf et al., 2016) .
Although RA patients compared to HC, in the present study, required significantly lower levels of pressure to experience pain at the most affected finger joint (Figure 2a) , there was no significant difference between groups in amount of pressure required to experience pain at the non-affected finger thumbnail. Within-group analyses revealed that healthy subjects needed significantly higher levels of pressure delivered to the joint compared to thumbnail in order to experience pain. Despite significantly different levels of pressure input between the two stimulation sites in HC, there were no significant differences in HC brain activation associated with painful pressure. However, within RA patients, the calibrated input pressure was equal for thumb and joint. Yet, despite equal input pressure levels, RA patients demonstrated statistically significantly more brain activation in response to painful pressure over the non-affected thumbnail compared to disease-affected joint. Our results stress the reliability and importance of using subjectively calibrated painful provocations, and that differences in brain activations in response to painful pressure are not simply reflecting the amount of pressure input delivered to the participants, but reflect disease-related abnormalities in painful processing in RA patients compared to HC.
Limitations
The current study constitutes of baseline data from a randomized, controlled double-blind clinical trial investigating the effects of the TNF-alpha inhibitor adalimumab regarding symptom severity and pain processing in RA. Therefore, the current sample is not representative of the RA population in general, as only patients with a clinical indication for treatment with adalimumab were included. A potential impact of steroid treatment cannot be excluded; however, these effects should be limited since no patient had doses higher than 10 mg/day. Future studies would benefit from larger sample sizes in order to increase the statistical sensitivity, although our cohort was fairly large for a clinical imaging study.
Conclusion
The current results indicate normal pain sensitivity and cerebral pain processing in RA (without fibromyalgia co-morbidity) for non-affected sites, while sensitivity at inflamed joints indicate peripheral/spinal sensitization. Brain imaging data suggest aberrant pain-and somatosensory processing in RA patients compared to HC; as well as within RA patients when comparing pain processing at disease-affected vs. non-affected sites. Further, when painfully stimulated over the disease-affected finger joint, RA patients exhibited significantly reduced activation in dorsolateral prefrontal cortex (dlPFC), which may indicate dysfunctional top-down regulation in RA patients during disease-relevant pain processing.
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